juliflorine has been researched along with Acute Confusional Senile Dementia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, VU; Ahmed, A; Azim, MK; Choudhary, MI; Ghayur, MN; Gilani, AU; Jalil, S; Khalid, A; Lodhi, MA; Nawaz, SA; Rode, BM | 1 |
1 other study(ies) available for juliflorine and Acute Confusional Senile Dementia
Article | Year |
---|---|
Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy.
Topics: Alkaloids; Alzheimer Disease; Animals; Binding Sites; Calcium; Calcium Channels; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation; Neutrophils; Protein Binding; Protein Conformation; Torpedo; Tyrosine | 2005 |